SEC Filing Summary: Amedica Corporation (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Amedica Corporation on October 11, 2017, reporting events from a Special Meeting of Stockholders held on October 10, 2017. The filing details the results of shareholder votes on corporate governance proposals. Note: The request metadata references "Sintx Technologies, Inc.," but the filing text explicitly identifies the registrant as Amedica Corporation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the outcome of a shareholder vote and contains no financial performance data.
Material Changes and Voting Results
Stockholders approved two key proposals at the Special Meeting:
- Proposal No. 1 (Reverse Stock Split): Approved an amendment to the Restated Certificate of Incorporation to effectuate a reverse stock split of Common Stock at a ratio between 1-for-2 and 1-for-15. The Board of Directors retains sole discretion to select the specific ratio within this range and may abandon the split. Fractional shares will be rounded up to the nearest whole share.
- Proposal No. 2 (Adjournment): Approved the ability to adjourn the meeting to solicit additional proxies if necessary to adopt the proposals.
Voting Breakdown for Proposal No. 1:
| Vote Type | Number of Shares |
|---|---|
| For | 18,211,006 |
| Against | 6,343,473 |
| Abstain | 168,131 |
| Broker Non-vote | 0 |
Guidance, Outlook, and Risks
The filing does not contain management commentary on financial guidance, future outlook, or specific risk factors beyond the corporate action of the reverse stock split. The primary contingency noted is the Board's discretion to determine the final split ratio or abandon the split entirely.
Key Facts for Investor Verification
- Verify the specific reverse stock split ratio selected by the Board of Directors, as the filing only authorizes a range (1-for-2 to 1-for-15).
- Confirm the effective date of the reverse stock split and the treatment of fractional shares (rounded up).
- Check subsequent filings for the updated share count and impact on trading status following the split.
- Ensure the correct company identity (Amedica Corporation) is being analyzed, as the metadata reference to Sintx Technologies appears to be an error.